You are viewing: Mexico Mental Health Screening Market analysis
Part of: Mental Health Screening Market (Global)

The Mexico Mental Health Screening Market was valued at $7.07 Million in 2023 and projected to reach to $13.44 Million by 2028, representing a compound annual growth rate of 11.3%. Mexico's mental health screening market is positioned for sustained growth through 2028, driven by increasing prevalence of mental health disorders and government initiatives to improve mental healthcare accessibility.

Mexico Mental Health Screening Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Mental Health Screening Market Trends and Insights

  • This growth trajectory in Mexico is driven by increasing awareness of mental health conditions, rising healthcare expenditures, and expanding access to diagnostic tools across both urban and rural regions.
  • Mexico's market expansion is supported by government initiatives promoting mental health awareness and integration of screening programs into primary healthcare systems. The mental health screening market in Mexico is experiencing accelerated adoption of digital and remote assessment technologies, particularly following increased demand for accessible mental health services.
  • Mexico's healthcare infrastructure is increasingly incorporating standardized screening protocols to identify depression, anxiety, and other prevalent mental health disorders early.
  • By 2028, Mexico is expected to see significant investment in mental health infrastructure, with both public and private sectors contributing to market growth through enhanced screening capabilities and improved patient outcomes..

Key Market Statistics

  • CAGR (2023-2028) 11.3% CAGR
  • Market Size, 2023 ~USD 7.07 Million
  • Forecast, 2028 ~USD 13.44 Million
  • Country Mexico

Mexico Mental Health Screening Market Overview

Market Valuation Growth :

Mexico's mental health screening market reached $7.07 million in 2023 and is expected to grow to $13.44 million by 2028, representing a robust 11.3% CAGR driven by increased mental health awareness and healthcare investment.

Rising Mental Health Awareness :

Growing recognition of mental health conditions across Mexican society is catalyzing demand for screening services, with both public and private healthcare sectors expanding diagnostic capabilities to address previously underdiagnosed populations.

Geographic Expansion :

Mental health screening services are expanding beyond urban centers into rural regions of Mexico, improving accessibility and creating new market opportunities as healthcare infrastructure develops in underserved areas.

Healthcare Expenditure Increase :

Rising healthcare spending in Mexico is enabling greater investment in mental health diagnostics and screening tools, supporting market expansion and adoption of advanced assessment technologies across clinical settings.

Mexico Mental Health Screening Market Dynamics

  • The market benefits from rising healthcare expenditures and growing recognition of mental health's importance in overall wellness.
  • Expanding diagnostic infrastructure in both urban and rural regions is creating new opportunities for screening service providers and technology vendors. Key growth drivers include enhanced healthcare awareness campaigns, integration of mental health screening into primary care settings, and adoption of digital diagnostic tools.
  • As Mexico's healthcare system continues modernizing, mental health screening is becoming increasingly integrated into routine clinical practice, supporting market expansion and improved patient outcomes across diverse demographic segments..

Related Ecosystem

Healthcare It

Top Technologies
  • Computed Tomography (CT)
  • Machine Learning
  • Magnetic Resonance Imaging (MRI)
  • Natural Language Processing (NLP)
  • Predictive Analytics
Top Companies
  • CERNER CORPORATION
  • PHILIPS HEALTHCARE
  • Oracle Corporation
  • GE HealthCare Technologies Inc.
  • Siemens healthineers

    Key Takeaways

    • Mexico's mental health screening market is projected to nearly double from $7.07M (2023) to $13.44M (2028) at an 11.3% CAGR.
    • Digital and remote screening technologies are rapidly gaining adoption across Mexico's healthcare system to improve accessibility.
    • Government mental health initiatives and primary care integration are key drivers of market expansion in Mexico.
    • Mexico's growing awareness of mental health conditions is creating sustained demand for standardized screening protocols and diagnostic tools.

    Mental Health Screening Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment COGNITIVE (Application)
    Forecast Period 2023-2028
    Growth Rate CAGR of 12.2% from 2023 to 2028
    Largest Segment ADULTS (AGE 19-64 YEARS) (Age Group)
    Market Size Base Year (Billions) ~USD 0.9 (2023)
    Revenue Forecast (Billions) ~USD 1.6 (2028)
    Segments Covered Application, Type, Screening Method, Technology, Age Group, Setting

    Mexico Mental Health Screening Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Application

    • Behavioral Disorders
    • Cognitive
    • Cognitive Disorders
    • Physiological Disorders
    • Psychiatric Disorders

    By Type

    • Aggression
    • Alzheimer'S Disease
    • Anxiety
    • Attention Deficit Hyperactivity Disorder (Adhd)
    • Beck Depression Inventory (Bdi)
    • Bipolar Disorder
    • Cognitive Impairment
    • Dementia
    • Depression
    • Diagnostic Interview For Psychological Distress (Dipd)
    • Dissociative Disorder
    • Eating Disorder
    • Generalized Anxiety Disorder-7 (Gad-7)
    • Hamilton Anxiety Rating Scale (Ham-A)
    • Hyperactivity
    • Mini International Neuropsychiatric Interview (Mini)
    • Obsessive Compulsive Disorder (Ocd)
    • Other Behavioral Disorders
    • Other Clinical Interviews
    • Other Cognitive Disorders
    • Other Physiological Disorders
    • Other Psychiatric Disorders
    • Other Self-Reported Questionnaires & Surveys
    • Patient Health Questionnaire-12 (Phq-12)
    • Post-Traumatic Stress Disorder (Ptsd)
    • Post-Traumatic Stress Disorder (Ptsd)
    • Psychotic Disorder
    • Schizophrenia
    • Self-Harm
    • Sleep Disorders
    • Social Withdrawal
    • Structured Clinical Interview For Dsm (Scid)
    • Structured Clinical Interviews For Dsm (Scid)
    • Substance Abuse
    • Yale-Brown Obsessive Compulsive Scale (Y-Bocs)

    By Screening Method

    • Biomarker Testing
    • Clinical Interviews
    • Observation-Based Assessments
    • Self-Reported Questionnaires & Surveys

    By Technology

    • AI-Based Screening Tools
    • Continuous Monitoring Wearable Devices
    • Remote Mental Health Platforms
    • Self-Screening Mhealth Apps
    • Telehealth & Virtual Care Solutions

    By Age Group

    • Adults (Age 19-64 Years)
    • Children & Adolescents (0-18 Years)
    • Children & Adolescents (Age 0-18 Years)
    • Seniors (Age 65 And Above)

    By Setting

    • Clinical Settings
    • Educational Institutions
    • Online Platforms
    • Other Settings
    • Workplace/Corporate Programs

    MEXICO: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BEHAVIORAL DISORDERS2.532.83.113.473.894.374.945.6112.3
    COGNITIVE DISORDERS1.862.072.312.592.923.33.744.2712.8
    PHYSIOLOGICAL DISORDERS6.437.077.798.619.5610.6611.9413.4411.3
    PSYCHIATRIC DISORDERS4.164.514.95.355.866.457.127.919.8
    TOTAL14.9816.4518.1220.0222.2324.7827.7531.2211.3

    Target Audience

    • Healthcare Providers & Clinics : Mexican healthcare facilities need market intelligence to understand demand for mental health screening services, plan service expansion, and optimize resource allocation in response to growing patient needs.
    • Medical Device & Diagnostic Companies : Manufacturers and distributors of mental health screening tools require Mexico-specific market data to assess market potential, identify distribution channels, and develop localized go-to-market strategies.
    • Healthcare Investors & Venture Capital : Investment firms evaluating opportunities in Mexico's healthcare sector need detailed market analysis to assess growth potential, identify promising startups, and make informed capital allocation decisions.
    • Government & Policy Makers : Mexican health authorities and policymakers require market insights to develop mental health initiatives, allocate healthcare budgets effectively, and design evidence-based mental health screening programs.
    • Pharmaceutical & Biotech Companies : Pharmaceutical firms need Mexico market data to understand mental health screening adoption rates, identify treatment gaps, and develop targeted commercial strategies for mental health medications and therapies.

    Reasons to Buy this Report

    • Market-Specific Growth Projections : Access detailed forecasts for Mexico's mental health screening market through 2028, enabling strategic planning and investment decisions based on country-specific growth trajectories and CAGR analysis.
    • Regional Expansion Opportunities : Identify high-potential areas for market entry and expansion across Mexico's urban and rural regions, with insights into geographic distribution of mental health screening demand and infrastructure development.
    • Competitive Landscape Intelligence : Understand the competitive dynamics specific to Mexico's mental health screening sector, including key players, market positioning, and opportunities for differentiation in this emerging market.
    • Healthcare Policy & Regulatory Insights : Gain comprehensive understanding of Mexico-specific healthcare regulations, reimbursement policies, and government initiatives affecting mental health screening adoption and market growth.
    • Investment & Partnership Strategy : Develop informed investment and partnership strategies tailored to Mexico's market conditions, with data-driven insights into stakeholder needs, market gaps, and growth acceleration opportunities.

    Frequently asked questions

    What is the current size of Mexico's mental health screening market?

    Mexico's mental health screening market was valued at $7.07 million in 2023 and is expected to reach $13.44 million by 2028.

    What is the projected growth rate for Mexico's mental health screening market?

    Mexico's mental health screening market is expected to grow at a compound annual growth rate (CAGR) of 11.3% from 2023 to 2028.

    What are the main drivers of growth in Mexico's mental health screening market?

    Key drivers include increasing mental health awareness, rising healthcare expenditures, government initiatives, digital technology adoption, and integration of screening into primary care systems across Mexico.

    How is technology impacting Mexico's mental health screening market?

    Digital and remote assessment technologies are accelerating adoption in Mexico, improving accessibility to mental health screening services in both urban and rural areas.

    What role does the government play in Mexico's mental health screening market?

    Mexico's government is actively promoting mental health awareness and supporting integration of screening programs into primary healthcare systems to expand market reach and improve patient outcomes.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Mental Health Screening market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Agency for Healthcare Research and Quality (AHRQ), Primary Care Companion for CNS Disorders Journal, Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    Breakdown of Primary Interviews

    Health Screening Market Size, and Share

    Note 1: Tiers are defined based on the total revenues of companies. As of 2022, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the mental health screening market was arrived at after data triangulation from various approaches, as mentioned below. After completing each approach, a weighted average of the three approaches was taken based on the level of assumptions used in each approach.

    Approach 1: Mental Health Screening Market (Revenue Share Analysis)

    • Revenues for individual companies were gathered from public sources and databases for each market segment.
    • Revenues of private companies were gathered through paid databases such as Factiva and Hoovers.
    • Shares of the mental health screening businesses of leading players were gathered from secondary sources to the extent available. In certain cases, shares have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, and geographic reach.
    • Individual shares or revenue estimates were validated through expert interviews.
    • The market size was then extrapolated to obtain the global market. It was further validated through expert interviews.

    Approach 2: Segmental Extrapolation

    Separate research approaches were followed to estimate the revenue from mental health screening tools and continuous monitoring wearable devices used for mental health screening.

    • Mental health screening tools (excluding continuous monitoring wearable devices):
    • The total number of psychiatrists in the US was determined for 2022. The percentage of psychiatrists using mental health screening tools offered by vendors was identified through extensive secondary research and validated through insights from primary interviews.
    • The average price of mental health screening tools for yearly subscriptions was considered to arrive at the US mental health screening market for clinical settings in 2022.
    • Considering the share of clinical settings, revenues of the overall market in the US were determined for 2022.
    • The US mental health screening market was extrapolated to arrive at the global market.
    • The market for continuous monitoring wearable devices:
    • The total prevalence of mental health disorders in the US was determined for 2022, and the share of people opting for assessments was identified through extensive secondary research and validated through insights from primary interviews.
    • The share of people using continuous monitoring wearable devices for mental health screening was assumed based on secondary research and insights from primary interviews.
    • The average price of continuous monitoring wearable devices was determined through secondary sources to arrive at the US market for continuous monitoring wearable devices.
    • The US market for continuous monitoring wearable devices was extrapolated to arrive at the global market for continuous monitoring wearable devices.
    • The sum of revenues from mental health screening tools and continuous monitoring wearable devices used for mental health screening provided the revenue of the global mental health screening market. The assumptions at each step were validated through primary interviews.

    Approach 3: Primary Interviews

    • As a part of the primary research process, individual respondents’ insights on the market size and growth were taken during the interview (regional and global, as applicable).
    • All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

    Data Triangulation:

    After arriving at the overall market size, from the market size estimation process explained above, the Mental Health Screening market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Mental Health Screening market.

    Market Definition:

    Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided.

    Screening tools may include questionnaires, surveys, or interviews that assess various aspects of an individual’s mental health, such as mood, behavior, thoughts, and emotions. These screenings are often administered by healthcare professionals, counselors, or mental health providers in different settings, including schools, workplaces, clinical settings, and others.

    Key Stakeholders:

    • Manufacturers of mental health screening solutions/products
    • Suppliers and distributors of mental health screening solutions/products
    • Third-party refurbishers/suppliers
    • Clinical settings
    • Educational institutions
    • Group purchasing organizations (GPOs)
    • Academic medical centers and universities
    • Corporate entities
    • Community centers
    • Government institutes
    • Market research & consulting firms
    • Contract manufacturing organizations (CMOs)
    • Venture capitalists & investors

    Report Objectives

    • To define, describe, and forecast the mental health screening market by application, screening method, technology, age group, setting, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall mental health screening market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile the key players in the market and comprehensively analyze their market shares and core competencies
    • To forecast the size of the market segments with respect to five main regions: North America, the Asia Pacific, Europe, Latin America, and the Middle East & Africa
    • To track and analyze competitive developments, such as partnerships, acquisitions, and launches
    • To benchmark players within the mental health screening market using the Competitive Evaluation Matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Available Customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Additional Company Profiling

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe mental health screening market into Spain, Italy, Russia, and others
    • Further breakdown of the Rest of Asia Pacific mental health screening market into Australia, South Korea, Singapore, and others

    Get the Full Mental Health Screening Market Report

    Full forecast, segment splits, and company analysis for all Mental Health Screening Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status